Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George F Murphy

Showing results (161-170 of 193) with videos related to

Pageof 20
Sort By:
Science Advances|January 19, 2024
Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signalingChristina Martins, Erik Rasbach, Markus V Heppt, et al.
Blood|May 21, 2011
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVLAlan M Hanash, Lucy W Kappel, Nury L Yim, et al.
Cancer Research|August 18, 2022
Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent TumorigenesisTobias Schatton, Yuta Itoh, Christina Martins, et al.
Clinical Epigenetics|July 30, 2015
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomasJonathan J Lee, Lynette M Sholl, Neal I Lindeman, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
The Journal of Investigative Dermatology|September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic MelanomaAsmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Pageof 20

Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
Science Advances|January 19, 2024
Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signalingChristina Martins, Erik Rasbach, Markus V Heppt, et al.
Blood|May 21, 2011
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVLAlan M Hanash, Lucy W Kappel, Nury L Yim, et al.
Cancer Research|August 18, 2022
Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent TumorigenesisTobias Schatton, Yuta Itoh, Christina Martins, et al.
Clinical Epigenetics|July 30, 2015
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomasJonathan J Lee, Lynette M Sholl, Neal I Lindeman, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
The Journal of Investigative Dermatology|September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic MelanomaAsmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Pageof 20